메뉴 건너뛰기




Volumn 18, Issue 6, 2001, Pages 345-352

Factors predicting compliance with Palivizumab in high-risk infants

Author keywords

Compliance; Low birth weight; Premature; Prevention; Respiratory syncytial virus

Indexed keywords

PALIVIZUMAB;

EID: 0034772776     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-17860     Document Type: Article
Times cited : (21)

References (22)
  • 5
    • 0031683919 scopus 로고    scopus 로고
    • Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants
    • (1998) Pediatrics , vol.102 , pp. 531-537
  • 7
    • 0031729747 scopus 로고    scopus 로고
    • Prevention of respiratory syncytial virus infections: Indications for the use of palivizumab and update on the use of RSV-IVIG
    • (1998) Pediatrics , vol.102 , pp. 1211-1216


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.